These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 8968914

  • 1. Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection.
    Zhang YQ, Mathiesen D, Kolbert CP, Anderson J, Schoen RT, Fikrig E, Persing DH.
    J Clin Microbiol; 1997 Jan; 35(1):233-8. PubMed ID: 8968914
    [Abstract] [Full Text] [Related]

  • 2. Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.
    Gomes-Solecki MJ, Wormser GP, Schriefer M, Neuman G, Hannafey L, Glass JD, Dattwyler RJ.
    J Clin Microbiol; 2002 Jan; 40(1):193-7. PubMed ID: 11773115
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.
    Wieneke CA, Lovrich SD, Callister SM, Jobe DA, Marks JA, Schell RF.
    J Clin Microbiol; 2000 Jan; 38(1):313-7. PubMed ID: 10618107
    [Abstract] [Full Text] [Related]

  • 4. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT, Rose CD, Budd SM, Gibney KM.
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [Abstract] [Full Text] [Related]

  • 5. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi.
    Golde WT, Burkot TR, Piesman J, Dolan MC, Capiau C, Hauser P, Dequesne G, Lobet Y.
    Vaccine; 1995 Apr; 13(5):435-41. PubMed ID: 7639011
    [Abstract] [Full Text] [Related]

  • 6. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.
    Chang YF, Appel MJ, Jacobson RH, Shin SJ, Harpending P, Straubinger R, Patrican LA, Mohammed H, Summers BA.
    Infect Immun; 1995 Sep; 63(9):3543-9. PubMed ID: 7642289
    [Abstract] [Full Text] [Related]

  • 7. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ, Berardi VP, Persing DH, Sigal LH.
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [Abstract] [Full Text] [Related]

  • 8. Effects of OspA vaccination on Lyme disease serologic testing.
    Aguero-Rosenfeld ME, Roberge J, Carbonaro CA, Nowakowski J, Nadelman RB, Wormser GP.
    J Clin Microbiol; 1999 Nov; 37(11):3718-21. PubMed ID: 10523583
    [Abstract] [Full Text] [Related]

  • 9. Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.
    Luke CJ, Huebner RC, Kasmiersky V, Barbour AG.
    Vaccine; 1997 Nov; 15(6-7):739-46. PubMed ID: 9178476
    [Abstract] [Full Text] [Related]

  • 10. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.
    Chang Y, Novosol V, McDonough SP, Chang CF, Jacobson RH, Divers T, Quimby FW, Shin S, Lein DH.
    Vaccine; 1999 Oct 14; 18(5-6):540-8. PubMed ID: 10519945
    [Abstract] [Full Text] [Related]

  • 11. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
    Wagner B, Freer H, Rollins A, Erb HN.
    Vet Immunol Immunopathol; 2011 Apr 15; 140(3-4):190-8. PubMed ID: 21208663
    [Abstract] [Full Text] [Related]

  • 12. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.
    Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT.
    J Clin Microbiol; 1999 Dec 15; 37(12):3990-6. PubMed ID: 10565920
    [Abstract] [Full Text] [Related]

  • 13. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
    Schaible UE, Wallich R, Kramer MD, Gern L, Anderson JF, Museteanu C, Simon MM.
    Vaccine; 1993 Dec 15; 11(10):1049-54. PubMed ID: 8212826
    [Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.
    Edelman R, Palmer K, Russ KG, Secrest HP, Becker JA, Bodison SA, Perry JG, Sills AR, Barbour AG, Luke CJ, Hanson MS, Stover CK, Burlein JE, Bansal GP, Connor EM, Koenig S.
    Vaccine; 1999 Feb 26; 17(7-8):904-14. PubMed ID: 10067697
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.
    Luke CJ, Carner K, Liang X, Barbour AG.
    J Infect Dis; 1997 Jan 26; 175(1):91-7. PubMed ID: 8985201
    [Abstract] [Full Text] [Related]

  • 17. A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
    Wressnigg N, Barrett PN, Pöllabauer EM, O'Rourke M, Portsmouth D, Schwendinger MG, Crowe BA, Livey I, Dvorak T, Schmitt B, Zeitlinger M, Kollaritsch H, Esen M, Kremsner PG, Jelinek T, Aschoff R, Weisser R, Naudts IF, Aichinger G.
    Clin Vaccine Immunol; 2014 Nov 26; 21(11):1490-9. PubMed ID: 25185574
    [Abstract] [Full Text] [Related]

  • 18. Acquired resistance to Borrelia burgdorferi infection in the rabbit. Comparison between outer surface protein A vaccine- and infection-derived immunity.
    Foley DM, Wang YP, Wu XY, Blanco DR, Lovett MA, Miller JN.
    J Clin Invest; 1997 Apr 15; 99(8):2030-5. PubMed ID: 9109448
    [Abstract] [Full Text] [Related]

  • 19. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes.
    Ma J, Bulger PA, Dante S, Davis DR, Perilli-Palmer B, Coughlin RT.
    J Infect Dis; 1995 Apr 15; 171(4):909-15. PubMed ID: 7706819
    [Abstract] [Full Text] [Related]

  • 20. Serologic surveillance for the Lyme disease spirochete, Borrelia burgdorferi, in Minnesota by using white-tailed deer as sentinel animals.
    Gill JS, McLean RG, Shriner RB, Johnson RC.
    J Clin Microbiol; 1994 Feb 15; 32(2):444-51. PubMed ID: 8150955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.